{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-050568","form_type":"8-K","ticker":"TMDX","cik":"0001756262","company_name":"TransMedics Group, Inc.","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.910419+00:00","generated_at":"2026-06-03T04:35:55.231735+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"TransMedics Q1 revenue $96.9M (+133% YoY), net income $12.2M; raises FY2024 revenue guide to $390-400M","bullets":["Q1 net revenue $96.9M (+133% YoY); net income $12.2M ($0.35 diluted EPS) vs net loss $2.6M in Q1 2023.","Gross margin 62% (down from 69% YoY) due to higher service revenue mix; operating expenses $47.5M.","Cash balance $350.2M at March 31, 2024.","FY2024 revenue guidance raised to $390-400M (from $360-370M), representing 61-66% YoY growth."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-050568","json":"https://secwatch.observer/filing/0000950170-24-050568.json","markdown":"https://secwatch.observer/filing/0000950170-24-050568.md","text":"https://secwatch.observer/filing/0000950170-24-050568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024050568/0000950170-24-050568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024050568/tmdx-20240430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T04:35:55.231735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f320818e85485f42d06e276ce838248f56807cb","claim":"TransMedics Group, Inc. reported quarter ended March 31, 2024 results: revenue $96.9 million, net income $12.2 million, EPS $0.35 per fully diluted share. Guidance raised.","evidence_excerpt":"Net revenue of $96.9 million in the first quarter of 2024, a 133% increase compared to the first quarter of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024050568/0000950170-24-050568-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended March 31, 2024"},{"label":"Revenue","value":"$96.9 million"},{"label":"Net income","value":"$12.2 million"},{"label":"EPS","value":"$0.35 per fully diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}